Integra LifeSciences Holdings Corporation (IART)

NASDAQ: IART · Real-Time Price · USD

16.04

-0.42 (-2.55%)

At close: May 29, 2026, 4:00 PM EDT

15.87

-0.17 (-1.06%)

After-hours: May 29, 2026, 7:02 PM EDT

IART Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,645	1,635	1,611	1,542	1,558	1,542
Revenue Growth (YoY)	1.24%	1.54%	4.47%	-1.03%	0.99%	12.43%
Cost of Revenue	790.34	803.63	728.47	656.84	587.36	597.81
Gross Profit	854.17	831.62	882.06	884.74	970.31	944.64
Selling, General & Admin	696.44	699.7	716.98	656.64	616.32	637.45
Depreciation & Amortization Expenses	15.03	14.95	21.29	12.38	13.88	16.91
Research & Development	97.74	98.97	115.38	104.19	101.19	93.05
Other Operating Expenses	511.37	511.37	-	-	-	-
Total Operating Expenses	1,321	1,325	853.65	773.21	731.39	747.41
Operating Income	-466.4	-493.37	28.41	111.53	238.92	197.23
Interest Income	18.16	18.47	20.04	17.2	11.92	6.74
Interest Expense	-89.91	-86.26	-70.63	-51.38	-49.59	-50.4
Other Non-Operating Income (Expense)	2.27	-2.35	3.94	3.72	12.65	61.11
Total Non-Operating Income (Expense)	-69.47	-70.13	-46.65	-30.46	-25.03	17.45
Pretax Income	-535.88	-563.5	-18.24	81.07	213.89	214.68
Provision for Income Taxes	-40.08	-47.03	-11.29	13.33	33.34	45.6
Net Income	-495.8	-516.47	-6.94	67.74	180.55	169.08
Net Income to Common	-495.8	-516.47	-6.94	67.74	180.55	169.08
Net Income Growth	-	-	-	-62.48%	6.79%	26.28%
Shares Outstanding (Basic)	77	77	77	80	83	85
Shares Outstanding (Diluted)	77	77	77	80	84	85
Shares Change (YoY)	0.14%	-0.44%	-4.14%	-3.81%	-2.30%	0.30%
EPS (Basic)	-6.46	-6.74	-0.09	0.85	2.18	2.00
EPS (Diluted)	-6.46	-6.74	-0.09	0.84	2.16	1.98
EPS Growth	-	-	-	-61.11%	9.09%	26.11%
Shares Outstanding	77.82	77.89	77.17	78.17	83.65	84.76
Free Cash Flow	4.08	-31.05	24.96	73.09	222.13	264.41
Free Cash Flow Growth	-	-	-65.84%	-67.09%	-15.99%	60.30%
Free Cash Flow Per Share	0.05	-0.40	0.32	0.91	2.66	3.09
Gross Margin	51.94%	50.86%	54.77%	57.39%	62.29%	61.24%
Operating Margin	-28.36%	-30.17%	1.76%	7.23%	15.34%	12.79%
Profit Margin	-30.15%	-31.58%	-0.43%	4.39%	11.59%	10.96%
FCF Margin	0.25%	-1.90%	1.55%	4.74%	14.26%	17.14%
EBITDA	-313.33	-341.54	169.3	235.04	357.22	317.07
EBITDA Margin	-19.05%	-20.89%	10.51%	15.25%	22.93%	20.56%
EBIT	-466.4	-493.37	28.41	111.53	238.92	197.23
EBIT Margin	-28.36%	-30.17%	1.76%	7.23%	15.34%	12.79%
Effective Tax Rate	7.48%	8.35%	61.92%	16.44%	15.59%	21.24%

SEC Filings: 10-K · 10-Q